Literature DB >> 8041853

Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.

D A Pegues1, M M Engelgau, C H Woernle.   

Abstract

Each year, it is estimated that from 350,000 to 739,000 U.S. infants are exposed in utero to one or more illicit drugs. To estimate the prevalence of and risk factors for illicit drug use by women of childbearing age in Alabama, during 2 months in 1991 the authors collected patient-reported histories, clinical histories, and urine specimens from 6,195 women statewide attending public health maternity clinics, family planning clinics, and a high-risk referral obstetrical clinic. Blind drug screening of urine specimens for marijuana, cocaine, opiates, barbiturates, and amphetamines was performed with the use of a fluorescent polarization immunoassay. The overall prevalence of positive results for drugs tested was 10.1 percent, including 8.4 percent of the 3,554 pregnant and 12.3 percent of the 2,571 nonpregnant women screened. The drugs most frequently detected were marijuana and cocaine. Characteristics of the subjects associated with a higher prevalence of positive results for any drug tested or for marijuana included white race, older age, being divorced, non student occupation, having 12 or less years of education, attending a clinic located in a suburban county, self-reported substance use, increased risk for human immunodeficiency virus infection, and reproductive history. Characteristics of women with positive screening for cocaine results were similar to those who tested positive for any drug, except that the prevalence of cocaine was higher among black women and those attending urban county clinics and did not vary by years of education. Patient-reported histories of drug use were insensitive in identifying women who had positive drug screening results (sensitivity, 6.3 percent; specificity, 98.2 percent). Thus, in this study,the use of illicit drugs among women of childbearing age attending public clinics in Alabama was common and emphasizes the need for targeted drug education and interventions to reduce the impact of drug use on this high-risk population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041853      PMCID: PMC1403530     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  17 in total

1.  Validity of self-reporting of marijuana and cocaine use among pregnant adolescents.

Authors:  B Zuckerman; H Amaro; H Cabral
Journal:  J Pediatr       Date:  1989-11       Impact factor: 4.406

2.  The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida.

Authors:  I J Chasnoff; H J Landress; M E Barrett
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

3.  Temporal patterns of cocaine use in pregnancy. Perinatal outcome.

Authors:  I J Chasnoff; D R Griffith; S MacGregor; K Dirkes; K A Burns
Journal:  JAMA       Date:  1989 Mar 24-31       Impact factor: 56.272

4.  Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome.

Authors:  M G Neerhof; S N MacGregor; S S Retzky; T P Sullivan
Journal:  Am J Obstet Gynecol       Date:  1989-09       Impact factor: 8.661

5.  Drug use and women: establishing a standard of care.

Authors:  I J Chasnoff
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

6.  Prevention of prematurity.

Authors:  F Fuchs
Journal:  Am J Obstet Gynecol       Date:  1976-12-01       Impact factor: 8.661

7.  Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital.

Authors:  L G Keith; S MacGregor; S Friedell; M Rosner; I J Chasnoff; J J Sciarra
Journal:  Obstet Gynecol       Date:  1989-05       Impact factor: 7.661

8.  The prevalence of substance abuse in patients with suspected preterm labor.

Authors:  J A Ney; S L Dooley; L G Keith; I J Chasnoff; M L Socol
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661

9.  The neonatal costs of maternal cocaine use.

Authors:  C S Phibbs; D A Bateman; R M Schwartz
Journal:  JAMA       Date:  1991-09-18       Impact factor: 56.272

10.  Drug abuse screening of childbearing-age women in Alabama public health clinics.

Authors:  S K George; J Price; J C Hauth; D M Barnette; P Preston
Journal:  Am J Obstet Gynecol       Date:  1991-10       Impact factor: 8.661

View more
  3 in total

1.  A pilot study of the nutritional status of opiate-using pregnant women on methadone maintenance therapy.

Authors:  Laura Elizabeth Tomedi; Debra L Bogen; Barbara H Hanusa; Katherine L Wisner; Lisa M Bodnar
Journal:  Subst Use Misuse       Date:  2012-02       Impact factor: 2.164

2.  Gestational age at enrollment and continued substance use among pregnant women in drug treatment.

Authors:  Mishka Terplan; Joanne Garrett; Katherine Hartmann
Journal:  J Addict Dis       Date:  2009

Review 3.  Universal alcohol/drug screening in prenatal care: a strategy for reducing racial disparities? Questioning the assumptions.

Authors:  Sarah C M Roberts; Amani Nuru-Jeter
Journal:  Matern Child Health J       Date:  2011-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.